NCT06996275 Attachment and Post-Traumatic Stress Disorder in Military Personnel: Characterization of the French Military Population, Exploration of Biopsychosocial Factors, and Study of the Impact of Security Priming on Emotional Contagion Capacities
| NCT ID | NCT06996275 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Direction Centrale du Service de Santé des Armées |
| Condition | Post-traumatic Stress Disorder (PTSD) |
| Study Type | OBSERVATIONAL |
| Enrollment | 94 participants |
| Start Date | 2025-05-28 |
| Primary Completion | 2027-05-26 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 94 participants in total. It began in 2025-05-28 with a primary completion date of 2027-05-26.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Post-traumatic stress disorder (PTSD) is a pathology that impairs the quality of life of sufferers. In military personnel, it can lead to military incapacity. This psychopathology is characterized by confrontation with one or more traumatic events in the individual's life history. Symptoms include cognitive and mood disorders, avoidance, hyperactivation (hypervigilance and anger) and intrusions (flashbacks and nightmares). Studies show that the prevalence of PTSD in military personnel fluctuates considerably from one situation to another (pre-deployment/post-deployment, etc.). In these at-risk populations, the often more complex PTSD clinic may also account for the heterogeneity of prevalences observed. Nevertheless, PTSD tends to become chronic in military personnel, making it particularly difficult to return to a "previous" state. In French casualties, beyond the symptoms already mentioned, complaints focus on difficulties in social interaction situations involving others in social life (attachment style to others) and in everyday life (public transport, supermarket shopping, social interactions, presence of crowds...). In the context of post-traumatic stress disorder, the investigators would like to explore the processes of social cognition that enable people to interact in their environment, in relation to biological, psychosocial and physiological variables that may constitute risk or maintenance factors for the pathology.
Eligibility Criteria
Inclusion Criteria: Inclusion Criteria Common to Both Groups: * Volunteers who agreed to participate in the study and provided written consent * Affiliated with social security * Proficient in the French language Inclusion Criteria Specific to the "Military Personnel with PTSD" Group: * Military personnel diagnosed with post-traumatic stress disorder related to their duties * Participants in activities offered by the wounded service support units Exclusion Criteria: * Adults subject to a protective measure * Refusal to participate in the study * Unrectified Legionnaires
Contact & Investigator
Anaïs Duffaud, PhD
STUDY DIRECTOR
Institut de Recherche Biomédicale des Armées
Frequently Asked Questions
Who can join the NCT06996275 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Post-traumatic Stress Disorder (PTSD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06996275 currently recruiting?
Yes, NCT06996275 is actively recruiting participants. Contact the research team at anais.duffaud@intradef.gouv.fr for enrollment information.
Where is the NCT06996275 trial being conducted?
This trial is being conducted at Brétigny-sur-Orge, France.
Who is sponsoring the NCT06996275 clinical trial?
NCT06996275 is sponsored by Direction Centrale du Service de Santé des Armées. The principal investigator is Anaïs Duffaud, PhD at Institut de Recherche Biomédicale des Armées. The trial plans to enroll 94 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.